Navigation Links
Medarex Announces 2008 Third Quarter Financial Results
Date:10/30/2008

p>Contract and license revenues $6,264 $6,973 $20,139 $20,771

Reimbursement of development

costs 3,944 5,454 12,032 14,990

Total revenues 10,208 12,427 32,171 35,761

Costs and expenses:

Research and development 44,153 49,165 146,019 141,460

General and administrative 11,068 13,149 35,912 35,020

Acquisition of in-process

technology - 6,900 - 6,900

Operating loss (45,013) (56,787) (149,760) (147,619)

Equity in net loss of affiliate (2,813) - (8,144) -

Interest income, net 1,919 3,635 162,233 162,981

Impairment loss on investments

in partners - - - (2,141)

Minority interest - Celldex - 1,602 - 4,542

Income (loss) before

provision for income taxes (45,907) (51,550) 4,329 17,763

Provision (benefit) for income

taxes (222) 5 (199) 7

Net income (loss) $(45,685) $(51,555) $4,528 $17,756

Basic net income (loss) per

share $(0.36) $(0.41) $0.04 $0.14

Diluted net income (loss) per

share $(0.36) $(0.41) $0.04 $0.14

Weighted average number of

common shares outstanding during

the year - basic 128,335 127,125 128,064 126,200

- diluted 128,335 127,125 128,064 128,501

Condensed Consolidated Balance Sheets

(In thousands)

September 30, December 31,


'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Primaryefficacyendpointhasbeenmetforpatientswitha... QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZe...lobalbiopharmaceuticalcompanyfocusedonendocrinethe...fromaPhase2studywithitstargetedcytotoxicpeptidecon...ncedorrecurrentendometrialcancer.Inapersonalizedhe...
(Date:11/24/2009)... REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/--...tRandyScott,GenomicHealth,sExecutiveChairman,willp...nceinNewYorkCityonTuesday,December1,2009at10:00a.m...ebcastofthepresentation,visittheInvestorRelationss...enomichealth.com .Pleaseconnecttothewebsiteatleast...
(Date:11/24/2009)... SEATTLE,Nov.24/PRNewswire-FirstCall/--CellTherape...esentatthe21stAnnualPiperJaffrayHealthCareConferen...wYorkPalaceHotel. ,, CTIwillpresentonTuesday,De...liveaudiowebcastofCTI,spresentationwillbeavailable...bleforreplayafterwards. , ,PiperJaffrayHealthCare...
(Date:11/23/2009)...ene consists of a two-dimensional carbon layer in ... lattice, resembling a honeycomb. Carbon nanotubes... of graphene sheets form graphite. Graphene boasts...y tear-resistant, an excellent thermal conductor, ...leness and ductility. In addition, graphene is imp...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2
...new statistical method that can estimate the origi...en causing anthrax, following detection of the fir...m the Medical Research Council (MRC) Centre for Ou...London in collaboration with the Health Protection... method, described in an article published April 1...
...HELL, WA, and VANCOUVER, April 9 /PRNewswire-First...x" or the "Company") (NASDAQ: OGXI ), announced ...s Company of the Year by LifeSciences British Colu...es British Columbia to recognize a local organizat... development of British Columbia,s life sciences i...
...AMAZOO, Mich., April 9 Tolera Therapeutics, Inc...ates Food and Drug Administration (FDA) for its in...cute rejection of solid organ transplantation. TOL...ly and specifically target T cells, components of ...ction, and ultimate failure, of transplanted organ...
Other Biology Technology:Novel method predicts impact of a covert anthrax release 2OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 2OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia 3Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug 2
(Date:11/24/2009)...d the American College of Medical Toxicology (ACMT...ublication of the Journal of Medical Toxicology ... in March 2010. It was previously published by th...nal of Medical Toxicology , an international, peer...cience and practice of medical toxicology. The qu...
(Date:11/24/2009)...se is available in Spanish . , The presence...s of inflammatory substances in the blood, hinders... by a research project of the University of Navarr...st at the School of Pharmacy. , The project, ent...lation to the control of body weight and inflammat...
(Date:11/23/2009)...dy by the Wildlife Conservation Society says that ...n the Republic of Congopart of the "mother lode" o...re becoming increasingly threatened by growing hum...ds protection of the swamp forests adjacent to the...r recent surveys confirmed that high densities of ...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2From Beginning to End E R Gets it Right 47827 1From Beginning to End E R Gets it Right 47827 2Key to Wound Healing May Be Explained in Fish Tail 47825 1Key to Wound Healing May Be Explained in Fish Tail 47825 2GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands 47821 1GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands 47821 2
...hunk of its tail fin, it,ll grow back within a wee... replace surprisingly complex body parts. A tail f... and is a very intricate structure. It is the fish...old-blooded animals re-grow missing tails and othe... scientists. They also wonder if people, and other...
...in the U.S. over the past 50 years has declined, a...to a study in the December 27 issue of JAMA. , Str... with more than 750,000 new strokes occurring each...g cause of death behind heart disease and cancer a...ility, according to background information in the ...
...garettes smoked every day in the belief that it wi...uggests research in Tobacco Control. , Although re... measure in smoking cessation, this study proves q...k caused by smoking is to quit, say the authors. ...men and women, all of whom were aged between 20 an...
Other Biology News:How does a zebrafish grow a new tail? 2How does a zebrafish grow a new tail? 3Incidence of stroke decreases over last 50 years 2Halving daily cigarette quota has no health benefit 2
...brary Panels were designed for full-length gene cl...ify the desired cDNA clone. The first PCR analysis...ach well contains plasmid DNA from 5,000 clones. H...rophoresis of the reaction products, the second PC...
...o Kit provides a fast and simple procedure for con...in samples. The kit is based on spin-column chroma...n ion exchanger. Salts such as MgCl2, NaCl, KCl, C...esin and are easily removed from the sample. The e...
...e Endostatin. Canine Cytokine EIA Kits,(Competi...nclude a line of enzyme-linked immunosorbent assay...research applications. The line of ELISA test kits... The quantitative test kits detect hormones, stero...
...taining Kit is a very sensitive immunohistochemica...ells, containing both anti-von Willebrand Factor a...to a variety of species. This AP kit provides a si... and paraffin-embedded sections in human (both CD3...
Biology Products: